| Descriptor English: | Etanercept | ||||||
| Descriptor Spanish: |
Etanercept
| ||||||
| Descriptor Portuguese: | Etanercepte | ||||||
| Descriptor French: | Étanercept | ||||||
| Entry term(s): |
Enbrel Erelzi Etanercept-szzs Fusion Protein, TNFR-Fc Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein TNF Receptor Type II IgG Fusion Protein TNF Receptor Type II-IgG Fusion Protein TNFR Fc Fusion Protein TNFR-Fc Fusion Protein TNR 001 TNR-001 TNR001 TNT Receptor Fusion Protein TNTR-Fc |
||||||
| Tree number(s): |
D12.644.541.500.697.624 D12.776.124.486.485.538.500.624 D12.776.124.486.485.680.697.624 D12.776.124.790.651.538.500.624 D12.776.124.790.651.680.660.624 D12.776.377.715.548.538.500.624 D12.776.377.715.548.680.660.624 D12.776.543.750.705.852.760.232 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068800 | ||||||
| Scope note: | A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Anti-Inflammatory Agents, Non-Steroidal Gastrointestinal Agents Immunosuppressive Agents Antirheumatic Agents |
||||||
| Registry Number: | OP401G7OJC | ||||||
| Public MeSH Note: | 2016; ETANERCEPT was indexed under IMMUNOGLOBULIN G and RECEPTORS, TUMOR NECROSIS FACTOR 1997-2015 |
||||||
| History Note: | 2016 (1997) |
||||||
| DeCS ID: | 55985 | ||||||
| Unique ID: | D000068800 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2016/01/01 | ||||||
| Date of Entry: | 2015/07/09 | ||||||
| Revision Date: | 2017/12/14 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Etanercept
- Preferred
TNFR-Fc Fusion Protein
- Narrower
Etanercept-szzs
- Narrower
TNF Receptor Type II-IgG Fusion Protein
- Narrower
Erelzi
- Narrower
Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein
- Narrower
Enbrel
- Narrower
| Concept UI |
M0276736 |
| Scope note | A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. |
| Preferred term | Etanercept |
| Concept UI |
M0276738 |
| Preferred term | TNFR-Fc Fusion Protein |
| Entry term(s) |
Fusion Protein, TNFR-Fc TNFR Fc Fusion Protein TNR 001 TNR-001 TNR001 TNT Receptor Fusion Protein TNTR-Fc |
| Concept UI |
M000638603 |
| Preferred term | Etanercept-szzs |
| Concept UI |
M0276735 |
| Preferred term | TNF Receptor Type II-IgG Fusion Protein |
| Entry term(s) |
TNF Receptor Type II IgG Fusion Protein |
| Concept UI |
M000638104 |
| Preferred term | Erelzi |
| Concept UI |
M0276737 |
| Preferred term | Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein |
| Entry term(s) |
Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein |
| Concept UI |
M0276734 |
| Preferred term | Enbrel |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
